ChemoCentryx, Inc. Business Operations Contracts & Agreements
15 Contracts & Agreements
- Collaboration Agreements (2 contracts)
- Development Agreements (9)
- Indemnification Agreements (2)
- Services Agreements (1)
- Supply Agreements (1)
- Manufacturing and Supply Agreement, effective as of October 29, 2020 between the Registrant and Vifor Fresenius Medical Care Renal Pharma Ltd (Filed With SEC on March 1, 2021)
- Master Manufacturing Services Agreement, dated as of March 18, 2020, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on August 10, 2020)
- Amendment to Collaboration and License Agreement, effective as of June 6, 2018 between the Registrant and Vifor Fresenius Medical Care Renal Pharma Ltd (Filed With SEC on August 9, 2018)
- COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on March 14, 2017)
- INDEMNIFICATION AGREEMENT (Filed With SEC on January 23, 2012)
- PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BETWEEN GLAXO GROUPLIMITED and CHEMOCENTRYX, INC. TABLE OF CONTENTS (Filed With SEC on January 6, 2012)
- AMENDMENT NO. 5 to PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on October 14, 2011)
- AMENDMENT NO. 4 to PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on October 14, 2011)
- AMENDMENT NO. 3 to PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on October 14, 2011)
- AMENDMENT NO. 2 to PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on October 14, 2011)
- AMENDMENT NO. 1 to PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on October 14, 2011)
- PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BETWEEN GLAXO GROUPLIMITED and CHEMOCENTRYX, INC. TABLE OF CONTENTS (Filed With SEC on October 14, 2011)
- INDEMNIFICATION AGREEMENT (Filed With SEC on January 14, 2008)
- to PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on December 20, 2007)
- PRODUCT DEVELOPMENT AND COMMERCIALIZATIONAGREEMENT BETWEEN GLAXO GROUP LIMITED and (Filed With SEC on December 20, 2007)
